ShapeTX Stock

shapetx.comHealthcare / BioTech & PharmaFounded: 2018Funding to Date: $138.25MM

Shape Therapeutics is a biotechnology company focused on developing breakthrough RNA technologies to shape the future of gene therapy.

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for ShapeTX, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access ShapeTX’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like ShapeTX.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

ShapeTX stock FAQs

plusminus

Can you buy ShapeTX stock?

As ShapeTX is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like ShapeTX, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.
plusminus

How to buy ShapeTX stock?

To invest in a private company like ShapeTX through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell ShapeTX stock?

Yes, you may be able to sell your ShapeTX stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell ShapeTX stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your ShapeTX stock on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.
plusminus

Is ShapeTX a public company?

No, ShapeTX is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is ShapeTX’s stock price?

ShapeTX is a privately held company and therefore does not have a public stock price. However, you may access ShapeTX’s private market stock price with Forge Data.
plusminus

What is ShapeTX’s stock ticker symbol?

ShapeTX does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Otsuka Pharmaceutical and Shape TX have announced a partnership to develop adeno-associated virus (AAV) gene therapies for eye diseases. The collaboration will leverage Shape TX's AI-driven AAVid platform and Otsuka's expertise in genetic payload design and ophthalmology. The deal includes an initial payment to Shape TX, along with potential development, regulatory, and sales milestone payments exceeding $1.5 billion.
Shape Therapeutics (Shape TX) plans to present seven presentations featuring its technology platforms at the 26th American Society for Gene and Cell Therapy Annual Meeting. The presentations will include new data from the company's RNAfix, RNAswap, AAVid, and TruStable platforms. Shape TX aims to use AI and RNA to end genetic diseases.
Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.